{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T03:22:14Z","timestamp":1777519334773,"version":"3.51.4"},"reference-count":47,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,2,4]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Homeostatic recovery after allogeneic HSCT favors the production, expansion, and survival of effector T cells over CD4Tregs. Unbalanced reconstitution of regulatory and effector T-cell subsets contributes to the development of chronic graft-versus-host disease.<\/jats:p>","DOI":"10.1182\/blood-2015-10-672345","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T22:24:23Z","timestamp":1450218263000},"page":"646-657","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":147,"title":["Unbalanced recovery of regulatory and effector T cells after allogeneic stem cell transplantation contributes to chronic GVHD"],"prefix":"10.1182","volume":"127","author":[{"given":"Ana C.","family":"Alho","sequence":"first","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"},{"name":"Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;"}]},{"given":"Haesook T.","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Computational Biology, and"},{"name":"Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA; and"},{"name":"Harvard Chan School of Public Health, Boston, MA"}]},{"given":"Marie J.","family":"Chammas","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"}]},{"given":"Carol G.","family":"Reynolds","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"}]},{"given":"Tiago R.","family":"Matos","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Edouard","family":"Forcade","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Jennifer","family":"Whangbo","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Sarah","family":"Nikiforow","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Corey S.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"John","family":"Koreth","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Vincent T.","family":"Ho","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Philippe","family":"Armand","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Joseph H.","family":"Antin","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Edwin P.","family":"Alyea","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Joao F.","family":"Lacerda","sequence":"additional","affiliation":[{"name":"Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal;"}]},{"given":"Robert J.","family":"Soiffer","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"}]},{"given":"Jerome","family":"Ritz","sequence":"additional","affiliation":[{"name":"Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA;"},{"name":"Harvard Medical School, Boston, MA;"},{"name":"Cancer Vaccine Center, Dana-Farber Cancer Institute, Boston, MA; and"}]}],"member":"234","reference":[{"issue":"19","key":"2019111902341217300_B1","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1182\/blood-2009-12-234096","article-title":"Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update.","volume":"115","author":"Seggewiss","year":"2010","journal-title":"Blood"},{"issue":"12","key":"2019111902341217300_B2","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/sj.bmt.1705381","article-title":"Rapid helper T-cell recovery above 200 x 10 6\/l at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation.","volume":"37","author":"Kim","year":"2006","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"2019111902341217300_B3","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s00281-008-0132-5","article-title":"Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.","volume":"30","author":"Storek","year":"2008","journal-title":"Semin Immunopathol"},{"issue":"4","key":"2019111902341217300_B4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.bbmt.2014.01.002","article-title":"Immune cell subset counts associated with graft-versus-host disease.","volume":"20","author":"Podgorny","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"2019111902341217300_B5","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1182\/blood-2007-06-096586","article-title":"Escape from suppression: tumor-specific effector cells outcompete regulatory T cells following stem-cell transplantation.","volume":"111","author":"Mirmonsef","year":"2008","journal-title":"Blood"},{"issue":"10","key":"2019111902341217300_B6","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1182\/blood-2013-02-482539","article-title":"Multiparameter single-cell profiling of human CD4+FOXP3+ regulatory T-cell populations in homeostatic conditions and during graft-versus-host disease.","volume":"122","author":"Dong","year":"2013","journal-title":"Blood"},{"issue":"8","key":"2019111902341217300_B7","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/bmt.2014.105","article-title":"Reconstitution of regulatory T-cell subsets after allogeneic hematopoietic SCT.","volume":"49","author":"Xhaard","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"2019111902341217300_B8","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/leu.2014.92","article-title":"Comparative analysis of FoxP3(+) regulatory T cells in the target tissues and blood in chronic graft versus host disease.","volume":"28","author":"Imanguli","year":"2014","journal-title":"Leukemia"},{"issue":"9","key":"2019111902341217300_B9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3324\/haematol.2014.104166","article-title":"Increased mitochondrial apoptotic priming of human regulatory T cells after allogeneic hematopoietic stem cell transplantation.","volume":"99","author":"Murase","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"2019111902341217300_B10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/imr.12163","article-title":"The importance of regulatory T-cell heterogeneity in maintaining self-tolerance.","volume":"259","author":"Yuan","year":"2014","journal-title":"Immunol Rev"},{"key":"2019111902341217300_B11","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.immunol.25.022106.141623","article-title":"Regulatory T cells: mechanisms of differentiation and function.","volume":"30","author":"Josefowicz","year":"2012","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2019111902341217300_B12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation.","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"issue":"7","key":"2019111902341217300_B13","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2004-03-1040","article-title":"Association of Foxp3 regulatory gene expression with graft-versus-host disease.","volume":"104","author":"Miura","year":"2004","journal-title":"Blood"},{"issue":"8","key":"2019111902341217300_B14","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1182\/blood-2005-03-1257","article-title":"Reduced frequency of FOXP3+ CD4+CD25+ regulatory T cells in patients with chronic graft-versus-host disease.","volume":"106","author":"Zorn","year":"2005","journal-title":"Blood"},{"issue":"9","key":"2019111902341217300_B15","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1172\/JCI76031","article-title":"Selective Treg reconstitution during lymphopenia normalizes DC costimulation and prevents graft-versus-host disease.","volume":"125","author":"Bolton","year":"2015","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111902341217300_B16","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy.","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"2019111902341217300_B17","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1182\/blood-2014-01-514752","article-title":"Current issues in chronic graft-versus-host disease.","volume":"124","author":"Soci\u00e9","year":"2014","journal-title":"Blood"},{"issue":"5","key":"2019111902341217300_B18","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri1355","article-title":"Concomitant regulation of T-cell activation and homeostasis.","volume":"4","author":"Grossman","year":"2004","journal-title":"Nat Rev Immunol"},{"issue":"8","key":"2019111902341217300_B19","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/eji.200939444","article-title":"Homeostatic proliferation and survival of naive and memory T cells.","volume":"39","author":"Boyman","year":"2009","journal-title":"Eur J Immunol"},{"issue":"6","key":"2019111902341217300_B20","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.immuni.2008.11.002","article-title":"Homeostasis of naive and memory T cells.","volume":"29","author":"Surh","year":"2008","journal-title":"Immunity"},{"issue":"3","key":"2019111902341217300_B21","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nri3605","article-title":"Homeostatic control of regulatory T cell diversity.","volume":"14","author":"Liston","year":"2014","journal-title":"Nat Rev Immunol"},{"issue":"25","key":"2019111902341217300_B22","doi-asserted-by":"crossref","first-page":"6768","DOI":"10.1182\/blood-2011-02-334623","article-title":"Thymic T-cell development in allogeneic stem cell transplantation.","volume":"117","author":"Krenger","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111902341217300_B23","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.coi.2007.04.015","article-title":"Cytokines and T-cell homeostasis.","volume":"19","author":"Boyman","year":"2007","journal-title":"Curr Opin Immunol"},{"issue":"12","key":"2019111902341217300_B24","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nri2657","article-title":"Naive T cell homeostasis: from awareness of space to a sense of place.","volume":"9","author":"Takada","year":"2009","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2019111902341217300_B25","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1182\/blood-2007-07-103895","article-title":"The impact of regulatory T cells on T-cell immunity following hematopoietic cell transplantation.","volume":"111","author":"Nguyen","year":"2008","journal-title":"Blood"},{"issue":"5","key":"2019111902341217300_B26","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1172\/JCI41072","article-title":"Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.","volume":"120","author":"Matsuoka","year":"2010","journal-title":"J Clin Invest"},{"issue":"4","key":"2019111902341217300_B27","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.cell.2014.10.026","article-title":"Spatial map of human T cell compartmentalization and maintenance over decades of life.","volume":"159","author":"Thome","year":"2014","journal-title":"Cell"},{"issue":"6754","key":"2019111902341217300_B28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions.","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"2019111902341217300_B29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.0105-2896.2006.00401.x","article-title":"Homeostasis of memory T cells.","volume":"211","author":"Surh","year":"2006","journal-title":"Immunol Rev"},{"issue":"11","key":"2019111902341217300_B30","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1002\/eji.200636976","article-title":"Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children.","volume":"37","author":"Junge","year":"2007","journal-title":"Eur J Immunol"},{"issue":"4","key":"2019111902341217300_B31","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1182\/blood-2008-02-139154","article-title":"Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets.","volume":"113","author":"Kohler","year":"2009","journal-title":"Blood"},{"issue":"5","key":"2019111902341217300_B32","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2184.1994.tb01421.x","article-title":"The proliferation-associated Ki-67 protein: definition in molecular terms.","volume":"27","author":"Duchrow","year":"1994","journal-title":"Cell Prolif"},{"key":"2019111902341217300_B33","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev.immunol.21.120601.141029","article-title":"Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more.","volume":"21","author":"Marsden","year":"2003","journal-title":"Annu Rev Immunol"},{"issue":"18","key":"2019111902341217300_B34","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2011-06-362137","article-title":"Low telomerase activity in CD4+ regulatory T cells in patients with severe chronic GVHD after hematopoietic stem cell transplantation.","volume":"118","author":"Kawano","year":"2011","journal-title":"Blood"},{"key":"2019111902341217300_B35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1146\/annurev-immunol-032712-100010","article-title":"The biology of recent thymic emigrants.","volume":"31","author":"Fink","year":"2013","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"2019111902341217300_B36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/ni.3150","article-title":"Peripheral regulatory T lymphocytes recirculating to the thymus suppress the development of their precursors.","volume":"16","author":"Thiault","year":"2015","journal-title":"Nat Immunol"},{"issue":"6","key":"2019111902341217300_B37","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ni.3171","article-title":"Thymic regulatory T cell niche size is dictated by limiting IL-2 from antigen-bearing dendritic cells and feedback competition.","volume":"16","author":"Weist","year":"2015","journal-title":"Nat Immunol"},{"issue":"1","key":"2019111902341217300_B38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1172\/JCI17601","article-title":"Memory CD4+ T cells do not induce graft-versus-host disease.","volume":"112","author":"Anderson","year":"2003","journal-title":"J Clin Invest"},{"issue":"7","key":"2019111902341217300_B39","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1172\/JCI81229","article-title":"Outcomes of acute leukemia patients transplanted with naive T cell-depleted stem cell grafts.","volume":"125","author":"Bleakley","year":"2015","journal-title":"J Clin Invest"},{"issue":"24","key":"2019111902341217300_B40","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1182\/blood-2013-03-489757","article-title":"A distinct evolution of the T-cell repertoire categorizes treatment refractory gastrointestinal acute graft-versus-host disease.","volume":"121","author":"Meyer","year":"2013","journal-title":"Blood"},{"issue":"179","key":"2019111902341217300_B41","doi-asserted-by":"crossref","first-page":"179ra43","DOI":"10.1126\/scitranslmed.3005265","article-title":"Low-dose interleukin-2 therapy restores regulatory T cell homeostasis in patients with chronic graft-versus-host disease.","volume":"5","author":"Matsuoka","year":"2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"2019111902341217300_B42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-065X.2011.01010.x","article-title":"Clinical tolerance in allogeneic hematopoietic stem cell transplantation.","volume":"241","author":"Roncarolo","year":"2011","journal-title":"Immunol Rev"},{"issue":"5","key":"2019111902341217300_B43","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.immuni.2009.04.006","article-title":"Human T regulatory cell therapy: take a billion or so and call me in the morning.","volume":"30","author":"Riley","year":"2009","journal-title":"Immunity"},{"issue":"22","key":"2019111902341217300_B44","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1056\/NEJMoa1108188","article-title":"Interleukin-2 and regulatory T cells in graft-versus-host disease.","volume":"365","author":"Koreth","year":"2011","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111902341217300_B45","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1182\/blood-2010-07-293795","article-title":"Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics.","volume":"117","author":"Brunstein","year":"2011","journal-title":"Blood"},{"issue":"8","key":"2019111902341217300_B46","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1158\/1078-0432.CCR-13-3205","article-title":"Ultra low-dose IL-2 for GVHD prophylaxis after allogeneic hematopoietic stem cell transplantation mediates expansion of regulatory T cells without diminishing antiviral and antileukemic activity.","volume":"20","author":"Kennedy-Nasser","year":"2014","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2019111902341217300_B47","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1182\/blood-2014-10-603449","article-title":"Ex vivo fucosylation of third-party human regulatory T cells enhances anti-graft-versus-host disease potency in vivo.","volume":"125","author":"Parmar","year":"2015","journal-title":"Blood"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/5\/646\/1395162\/646.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/5\/646\/1395162\/646.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T02:36:26Z","timestamp":1574130986000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/5\/646\/35103\/Unbalanced-recovery-of-regulatory-and-effector-T"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,4]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,2,4]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-10-672345","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,4]]}}}